High Performance Computing of Personalized Cardio Component Models
NCT ID: NCT02235883
Last Updated: 2018-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
94 participants
OBSERVATIONAL
2014-08-31
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Assessment Of Myocardial Viability Based On CTA/MRI Hybrid Models
NCT04397198
Warning Model of Myocardial Remodeling After Acute Myocardial Infarction Using Multimodal Feature Structure Technology
NCT06062316
Multiomics and Imaging-based Assessment of Vulnerable Coronary Plaques in Acute Coronary Syndromes
NCT03391908
Systemic, Pancoronary and Local Coronary Vulnerability
NCT03606330
a Foundational Model for Cardiovascular Disease Diagnosis and Prediction
NCT06591923
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Comprehensive modeling of the anatomical and hemodynamic phenomena in the coronary circulation based on input data acquired from both angiography and echocardiography;
* Assessment of functional parameters and subsequent validation of the models;
* High performance computing architecture for efficiently addressing the multi-scale complexity, which is a critical requirement for translation into clinical decision making.
Patient measurements used as input data for the multiscale models, or for validating the computational results include:
* Angiography: targeted angiographic views include LAO 30, LAO 30/20 cranial, LAO 30/20 caudal, RAO 30 (RCA views) and RAO 25/25 caudal, RAO 0/40 caudal, RAO 10/40 cranial, LAO 50/20 cranial, LAO 50/20 caudal (LCA views)
* Echocardiography:
* Standard apical acquisitions (2D harmonic 4-chamber, 2-chamber, 3-chamber)
* Color flow Doppler/spectral Doppler (MR, AI, TR evaluation; CW and PW spectral Doppler)
* Three-dimensional imaging (From apical 4-chamber view one ECG-triggered real time complete full volume acquisition including LV and LA - 1 acquisition at low volume per second (VPS) rate and one at high VPS, real time volumetric color flow Doppler, cover MV and AV).
* Non-invasive pressure measurements: cuff-based measurements at the left and right arm, before echocardiography and angiography
* Invasive pressure measurements: rest - aortic pressure (Pa), distal pressure (Pd), Pd/Pa ratio; hyperemia - aortic pressure (Pa), distal pressure (Pd), FFR (Pd/Pa)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* providing written informed consent
* scheduled to undergo clinically-indicated non-emergent invasive coronary angiography (ICA)
* likelihood of stenosis in one of the main coronary epicardial vessels (LAD, LCx, RCA)
Exclusion Criteria
* prior bypass surgery
* prior valve surgery or replacement
* significant arrhythmia
* very low systolic BP (\<90 mmHg)
* abnormally high HR (\>120 bpm)
* significant Left Main disease
* STEMI or NSTEMI
* suspected microvascular disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Spitalul Clinic de Urgenţǎ Bucureşti
UNKNOWN
Siemens Corporate Technology Romania
INDUSTRY
Universitatea Politehnica Bucureşti
UNKNOWN
Transilvania University of Brasov
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lucian Itu
Conf. dr. ing. Constantin Suciu
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Constantin Suciu, Conf. dr. ing.
Role: PRINCIPAL_INVESTIGATOR
Siemens Corporate Technology Romania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Spitalul Clinic de Urgenţǎ Bucureşti
Bucharest, , Romania
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
130_2012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.